Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-04-05
2008-08-19
Saunders, David A (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S093710, C435S002000, C435S372000, C435S372200
Reexamination Certificate
active
07413869
ABSTRACT:
The present invention discloses methods useful in the preparation of immunostimulatory vaccines which include as one of their components, activated antigen presenting cells which are characterized by having an ability to stimulate a therapeutic T cells response in vivo.
REFERENCES:
patent: 5252556 (1993-10-01), Ardman
patent: 5976546 (1999-11-01), Laus et al.
patent: 6010905 (2000-01-01), Cohen et al.
patent: 6080409 (2000-06-01), Laus et al.
patent: 6121044 (2000-09-01), Peshwa et al.
patent: 6210662 (2001-04-01), Laus et al.
patent: 6558951 (2003-05-01), Tomai et al.
patent: 7060279 (2006-06-01), Laus et al.
patent: 2002/0094545 (2002-07-01), Harris et al.
patent: 2003/0108527 (2003-06-01), Seya et al.
patent: 2004/0033213 (2004-02-01), Walker et al.
patent: WO 01/48154 (2001-07-01), None
Laitinen, H.A., Chemical Anallysis, an advanced text and reference, McGraw-Hill Book Company, Inc., 1960, pp. 537-548.
Austyn, J.M. et al., Dendritic Cells in the Blood Transfusion Effect,Trans Proc 19(1):1434 (1987).
Austyn, J.M. et al., Lymphoid dendritic cells,Immunology 62:161-170 (1987).
Austyn, J.M. et al., T cell activation by anti-CD3 antibodies: function of Fc receptors on B cell blasts, but not resting B cells, and CD18 on the responding T cells,Eur J Immunol 27:1329-1335 (1987).
Caux, C. et al., Characterization of Human CD34+Derived Dendritic/Langerhans Cells (D-Lc),Proceedings of the 3rdInternational Symposium on Dendritic Cells in Fundamental and Clinical Immunology(Jun. 19-23, 1994) 2:1-5 (1995).
Caux, C. et al., Human Dendritic Langerhans Cells Generated In Vitro from CD34+Progenitors Can Prime Naïve CD34+T Cells and Process Soluble Antigen,J Immunol5427-5435 (1995).
Caux, C. et al., Recent advances in the study of dendritic cells and follicular dendritic cells,Immunol Today 16:(1)2-4 (1995).
Cui, Y. et al., Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells,Blood 99(2):399-408 (2002).
Fong, L. et al., Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer,J Immunol 159:3113-3117. (1997).
Gratama, J.W. et al., Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives,Cytometry 33:166-178 (1998).
Hart, D.N.J., et al., Interstitial Dendritic Cells,Intern Rev Immunol 6:127-138 (1990).
Henderson, L.O. et al., Terminology and nomenclature for standardization in quantitative fluorescence cytometry,Cytometry 33:97-105 (1998).
Hsu, F.J. et al., Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells,Nat Med 2(1):52-58 (1996).
Kuciel, R. et al., Characterization of anti-prostatic acid phosphatase monoclonal antibody and its medical significance,Biotechnol Appl Biochem 10:257-272 (1988).
Laus, R. et al., Dendritic cell immunotherapy of prostate cancer: Preclinical models and early clinical experience,Cancer Research Therapy and Control 111-10 (2001).
Lenkei, R. et al., Performance of calibration standards for antigen quantitation with flow cytometry,Cytometry 33:188-186 (1998).
Pacanowski, J. et al., Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection,Blood 98(10):3016-3021 (2001).
Reichardt, V.L. et al., Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study,Blood 93(7):2411-2419 (1999).
Schwartz, A. et al., Standardizing flow cytometry: a classification system of fluorescence standards used for flow cytometry,Cytometry 33:106-114 (1998).
Small, E.J. et al., Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells,J Clin Oncol 18(23):3894-3903 (2000).
Steinman, R., The Dendritic Cell System and Its Role in Immunogenicity,Annu Rev Immunol 9:271-296 (1991).
Van Schooten, WCA et al., Biological properties of dendritic cells: Implications to their use in the treatment of cancer,Mol. Med. Today 3:254-260 (1997).
Law Ping
Peshwa Madhusudan V.
Dehlinger Peter J.
Dendreon Corporation
King & Spalding LLP
Myers Fitch Susan J.
Saunders David A
LandOfFree
Method for determining potency of antigenic presenting cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining potency of antigenic presenting cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining potency of antigenic presenting cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993926